Free Trial

Actinium Pharmaceuticals (ATNM) Short Interest Ratio & Short Volume

$7.11
-0.11 (-1.52%)
(As of 07/19/2024 08:55 PM ET)

Actinium Pharmaceuticals Short Interest Data

Current Short Interest
1,880,000 shares
Previous Short Interest
1,710,000 shares
Change Vs. Previous Month
+9.94%
Dollar Volume Sold Short
$0.00
Short Interest Ratio
6.9 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
29,780,000 shares
Percentage of Shares Shorted
6.31%
Today's Trading Volume
92,700 shares
Average Trading Volume
295,127 shares
Today's Volume Vs. Average
31%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Actinium Pharmaceuticals ?

Sign up to receive the latest short interest report for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ATNM Short Interest Over Time

ATNM Days to Cover Over Time

ATNM Percentage of Float Shorted Over Time

Actinium Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20241,880,000 shares $0.00 +9.9%N/A6.9 $0.00
6/15/20241,710,000 shares $0.00 -5.5%N/A5.7 $0.00
5/31/20241,810,000 shares $0.00 -13.4%N/A4.6 $0.00
5/15/20242,090,000 shares $0.00 -10.3%N/A5.2 $0.00
4/30/20242,330,000 shares $0.00 +17.7%N/A6.2 $0.00
4/15/20241,980,000 shares $0.00 -9.6%N/A5.6 $0.00
3/31/20242,190,000 shares $0.00 +20.3%N/A6.6 $0.00
3/15/20241,820,000 shares $12.29 million +1.1%N/A5.8 $6.75
2/29/20241,800,000 shares $15.35 million -3.2%N/A8.3 $8.53
2/15/20241,860,000 shares $0.00 +0.5%N/A8.5 $0.00
1/31/20241,850,000 shares $9.95 million -7.0%N/A9.1 $5.38
1/15/20241,990,000 shares $0.00 +2.1%N/A9.4 $0.00
12/31/20231,950,000 shares $0.00 +2.6%N/A9.4 $0.00
12/15/20231,900,000 shares $0.00 -6.9%N/A9.4 $0.00
11/30/20232,040,000 shares $9.34 million +10.3%N/A10.5 $4.58
11/15/20231,850,000 shares $0.00 -7.5%N/A9.7 $0.00
10/31/20232,000,000 shares $0.00 -2.0%N/A10.7 $0.00
10/15/20232,040,000 shares $0.00 -1.0%N/A12.1 $0.00
9/30/20232,060,000 shares $0.00 +5.6%N/A12.2 $0.00
9/15/20231,950,000 shares $0.00 -5.3%N/A11.7 $0.00
8/31/20232,060,000 shares $0.00 -2.4%N/A9.2 $0.00
8/15/20232,110,000 shares $0.00 No ChangeN/A9.9 $0.00
7/31/20232,110,000 shares $0.00 -0.9%N/A9.7 $0.00
7/15/20232,130,000 shares $0.00 -0.5%N/A8.8 $0.00
6/30/20232,140,000 shares $0.00 +27.4%N/A8.7 $0.00
6/15/20231,680,000 shares $0.00 +37.7%N/A6.6 $0.00
5/31/20231,220,000 shares $10.13 million -29.1%N/A5.8 $8.30
5/15/20231,720,000 shares $0.00 +30.3%N/A4.8 $0.00
4/30/20231,320,000 shares $0.00 -27.5%N/A3.4 $0.00
4/15/20231,820,000 shares $0.00 -4.2%N/A4.7 $0.00
3/31/20231,900,000 shares $17.96 million +31.9%N/A4.6 $9.45
3/15/20231,440,000 shares $13.45 million -2.0%N/A3.5 $9.34
2/28/20231,470,000 shares $14.19 million -9.8%N/A3.6 $9.65
2/15/20231,630,000 shares $0.00 +4.5%N/A3.9 $0.00
1/31/20231,560,000 shares $18.28 million +39.3%N/A5 $11.72
1/15/20231,120,000 shares $0.00 +0.9%N/A2 $0.00
12/30/20221,110,000 shares $11.82 million -3.5%N/A2.1 $10.65
12/15/20221,150,000 shares $0.00 -6.5%N/A2.2 $0.00
11/30/20221,230,000 shares $0.00 +36.8%N/A2.5 $0.00
11/15/2022899,200 shares $0.00 +84.9%N/A1.8 $0.00
Brace Yourself: Experts calling for Bitcoin to hit $100k (Ad)

For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.

Click here to get The Crypto Bull Run Millionaire Blueprint now.
10/31/2022486,400 shares $0.00 +23.2%N/A1.1 $0.00
10/15/2022394,900 shares $0.00 +5.3%N/A2.8 $0.00
9/30/2022374,900 shares $0.00 +6.4%N/A2.8 $0.00
9/15/2022352,500 shares $0.00 -10.2%N/A2.5 $0.00
8/31/2022392,700 shares $0.00 +5.7%N/A2.9 $0.00
8/15/2022371,500 shares $0.00 +2.7%N/A3 $0.00
7/31/2022361,700 shares $0.00 -2.7%N/A2.2 $0.00
7/15/2022371,700 shares $1.88 million -15.8%N/A1.6 $5.05
6/30/2022441,500 shares $0.00 -20.5%N/A0.5 $0.00
6/15/2022555,300 shares $0.00 -23.9%N/A0.6 $0.00
5/31/2022729,900 shares $0.00 -17.3%N/A0.8 $0.00
5/15/2022883,000 shares $0.00 -4.8%N/A1 $0.00
4/30/2022927,200 shares $0.00 -30.8%N/A1.1 $0.00
4/15/20221,340,000 shares $0.00 +137.7%N/A1.7 $0.00
3/31/2022563,800 shares $2.88 million -4.2%N/A6.3 $5.11
3/15/2022588,500 shares $0.00 -5.1%N/A5.8 $0.00
2/28/2022620,300 shares $0.00 -26.4%N/A5.7 $0.00
2/15/2022843,100 shares $0.00 +0.7%N/A7.5 $0.00
1/31/2022837,500 shares $4.53 million -3.2%N/A7.1 $5.41
1/15/2022864,900 shares $0.00 +1.0%N/A6.8 $0.00
12/31/2021856,800 shares $5.15 million -0.5%N/A6.6 $6.01
12/15/2021860,700 shares $0.00 -3.4%N/A5.1 $0.00
11/30/2021891,200 shares $6.39 million -8.9%N/A4.1 $7.17
11/15/2021977,900 shares $0.00 -6.0%N/A4.2 $0.00
10/29/20211,040,000 shares $8.16 million -1.0%N/A4.4 $7.85
10/15/20211,050,000 shares $0.00 -6.3%N/A4.5 $0.00
9/30/20211,120,000 shares $0.00 +36.3%5.6%4.7 $0.00
9/15/2021821,700 shares $0.00 -1.6%4.1%3.7 $0.00
8/31/2021834,700 shares $0.00 -13.1%4.2%4.9 $0.00
8/13/2021960,700 shares $0.00 -3.0%4.8%5.6 $0.00
7/30/2021989,900 shares $0.00 +5.4%5.0%5.9 $0.00
7/15/2021939,500 shares $0.00 +3.0%4.7%5.4 $0.00
6/30/2021912,300 shares $0.00 +16.4%4.6%4.9 $0.00
6/15/2021783,700 shares $0.00 -8.6%4.0%3.5 $0.00
5/28/2021857,100 shares $0.00 -3.3%4.4%4 $0.00
5/14/2021886,600 shares $0.00 +2.6%4.6%3.7 $0.00
4/30/2021864,400 shares $0.00 -6.7%4.7%3 $0.00
4/15/2021926,500 shares $6.84 million -1.2%5.1%2.7 $7.38
3/31/2021937,700 shares $7.37 million +7.4%5.1%2.4 $7.86
3/15/2021873,100 shares $6.78 million +8.7%6.8%1.8 $7.76
2/26/2021803,300 shares $6.67 million +14.5%6.2%1.5 $8.30
2/12/2021701,500 shares $5.65 million -13.0%5.4%1.3 $8.06
1/29/2021806,700 shares $6.56 million -20.9%6.0%1.5 $8.13
1/15/20211,020,000 shares $9.69 million -3.8%7.5%2 $9.50
12/31/20201,060,000 shares $8.65 million +3.9%7.8%2.1 $8.16
12/15/20201,020,000 shares $11.97 million +29.1%7.5%2.7 $11.74
11/30/2020790,300 shares $8.84 million +18.6%5.8%2.2 $11.19
11/15/2020666,300 shares $8.00 million +1.7%4.9%1.9 $12.01
10/30/2020654,900 shares $6.68 million +22.0%4.8%1.7 $10.20
10/15/2020536,800 shares $5.95 million -4.8%4.0%1.1 $11.08
Brace Yourself: Experts calling for Bitcoin to hit $100k (Ad)

For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.

Click here to get The Crypto Bull Run Millionaire Blueprint now.
9/30/2020563,600 shares $5.46 million -5.6%4.2%1 $9.69
9/15/2020596,700 shares $5.61 million -6.5%4.4%1 $9.41
8/31/2020638,000 shares $5.30 million +63.6%4.7%0.9 $8.31
8/14/2020390,000 shares $3.83 million -97.1%3.0%0.5 $9.82
7/31/202013,540,000 shares $7.80 million +214.2%N/A18 $0.58
7/15/20204,310,000 shares $1.50 million -26.1%N/A0.2 $0.35
6/30/20205,830,000 shares $2.08 million +120.0%N/A0.4 $0.36
6/15/20202,650,000 shares $1.08 million -0.8%N/A0.2 $0.41
5/29/20202,670,000 shares $550,020.00 +38.3%N/A0.3 $0.21
5/15/20201,930,000 shares $345,470.00 +37.9%N/A0.4 $0.18
4/30/20201,400,000 shares $258,300.00 -47.2%0.9%0.3 $0.18
4/15/20202,650,000 shares $514,365.00 +11.8%N/A0.7 $0.19
3/31/20202,370,000 shares $426,600.00 -10.4%1.6%0.8 $0.18
3/13/20202,643,900 shares $528,780.00 +23.6%N/A0.8 $0.20
2/28/20202,140,000 shares $385,200.00 +0.9%1.4%0.6 $0.18
2/14/20202,120,000 shares $530,000.00 -1.9%1.4%0.7 $0.25
1/31/20202,160,000 shares $518,400.00 -6.5%1.4%0.8 $0.24
1/15/20202,310,000 shares $531,300.00 -34.0%1.5%0.7 $0.23
12/31/20193,500,000 shares $875,000.00 +22.8%2.2%1.2 $0.25

ATNM Short Interest - Frequently Asked Questions

What is Actinium Pharmaceuticals' current short interest?

Short interest is the volume of Actinium Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 1,880,000 shares of ATNM short. Learn More on Actinium Pharmaceuticals' current short interest.

What is a good short interest ratio for Actinium Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATNM shares currently have a short interest ratio of 7.0. Learn More on Actinium Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Actinium Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Actinium Pharmaceuticals: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Actinium Pharmaceuticals' short interest increasing or decreasing?

Actinium Pharmaceuticals saw a increase in short interest in June. As of June 30th, there was short interest totaling 1,880,000 shares, an increase of 9.9% from the previous total of 1,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Actinium Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Actinium Pharmaceuticals: Cogent Biosciences, Inc. (10.12%), Praxis Precision Medicines, Inc. (9.21%), 89bio, Inc. (6.53%), ABIVAX Société Anonyme (0.17%), Nuvation Bio Inc. (7.62%), Dianthus Therapeutics, Inc. (11.44%), Harrow, Inc. (16.25%), AnaptysBio, Inc. (20.07%), Immunome, Inc. (4.42%), Aurinia Pharmaceuticals Inc. (7.23%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Actinium Pharmaceuticals stock?

Short selling ATNM is an investing strategy that aims to generate trading profit from Actinium Pharmaceuticals as its price is falling. ATNM shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Actinium Pharmaceuticals?

A short squeeze for Actinium Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNM, which in turn drives the price of the stock up even further.

How often is Actinium Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNM, twice per month. The most recent reporting period available is June, 30 2024.



This page (NYSEAMERICAN:ATNM) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners